相关实验视频
Updated: Jan 10, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
877
黄金-PCP研究:临床医生对以人为中心的包装设计的见解,用于2型糖尿病治疗的三重固定剂量组合
Chitra Selvan1, Lakshmi Nagendra2, Parth Jethwani3
1Endocrinology, M. S. Ramaiah Medical College, Bengaluru, IND.
Cureus
|November 28, 2025
概括
印度的临床医生认为以人为中心的包装 (PCP) 和固定剂量组合 (FDC) 对于改善2型糖尿病药物服药性和简化治疗方案是有益的. 建议进行进一步的患者研究,以证实这些积极的看法.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 患者坚持的研究研究.
背景情况:
- 2型糖尿病的管理受到药物坚持问题的挑战,特别是多药.
- 固定剂量组合 (FDC) 和以人为中心的包装 (PCP) 是通过降低药片负担和提高可用性来潜在地提高药物的坚持的策略.
- 黄金-PCP研究调查了医疗保健提供者对PCP在糖尿病治疗中的作用的看法.
研究的目的:
- 评估临床医生对以人为中心的包装 (PCP) 对2型糖尿病患者药物坚持的影响的看法.
- 评估临床医生对PCP和固定剂量组合 (FDC) 如何影响整体治疗管理和患者体验的看法.
主要方法:
- 在印度对262名临床医生进行了横截面调查,这些医生至少六个月以来一直处方PCP的FDC.
- 经过验证的12项调查问卷被用于在结构化圆桌会议后收集临床医生的看法.
- 数据分析包括描述性统计数据和使用IBM SPSS统计数据的Pearson相关性.
主要成果:
- 高比例的临床医生认为,PCP有助于提高患者的坚持 (83.2%),简化治疗 (82.1%),以及药物识别 (82.0%).
- 大多数临床医生 (80.9%) 认为FDCs减少了药丸负担. 花式PCP设计与患者偏好增加 (78.6%),药房替代减少 (80.1%),遗漏剂量减少 (80.2%).
- 在感知降低药物负担和感知改善药物坚持之间发现了显著的正相关性 (r = 0.883,p < 0.001).
结论:
- 临床医生认为以人为中心的包装 (PCP) 是一种有价值的工具,可以提高药物遵守率,并简化2型糖尿病的治疗.
- 该研究强调了PCP和FDC在应对遵守挑战方面的潜在好处.
- 为了验证这些临床医生的看法,需要进行进一步的研究,包括客观的坚持指标和患者报告的结果.
相关概念视频
Dosage Regimens: Designs and Approaches
242
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
242
Biopharmaceutical Factors Influencing Drug Product Design: Overview
222
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
222
Insulin Formulations: Types and Delivery
622
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
622
Dosage Regimen: Individualization
154
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
154
Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K

